OPKO Health Sees Q2 Sales $127.000M-$132.000M vs $136.329M Est

Benzinga Newsdesk www.benzinga.com Positive 80.1%

Neg 0% Neu 0% Pos 80.1%

OPKO Health (NASDAQ:OPK) sees Q2 sales of $127.000 million-$132.000 million vs $136.329 million analyst estimate.

Comments

No comments yet. Be the first!